MentionFox
Home › funding signals › Wyndly
Accelerator · announced

Wyndly (YC W21) — Life's better without allergies

Before you sell to, join or invest in Wyndly

MentionFox check on Wyndly: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/yc-wyndly

Check Wyndly before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Wyndly?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Wyndly (https://www.wyndly.com) fixes allergies by training patients' bodies to ignore their allergy triggers. Frustrated allergy suffers come to us when they no longer want to deal with pills and sprays.

Wyndly is a Y Combinator company in the Winter 2021 batch. Its directory entry describes it as: Life's better without allergies. The founders listed are Aakash Shah (Founder/CEO), Manan Shah (Founder) (Y Combinator directory entry, February 6, 2021).

6 more companies from YC Winter 2021 ↓

Run the free check on Wyndly →

Sell to companies like Wyndly? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Wyndly

New accelerator entry · 2021-02-06 · the record

Winter 2021
batch
18
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2021
Announced2021-02-06
StageEarly
StatusActive
Team size18
IndustryHealthcare
Sub-industryHealthcare -> Consumer Health and Wellness
SectorsConsumer Health Services, Consumer, Digital Health, Healthcare
RegionsUnited States of America, America / Canada, Remote, Fully Remote
BasedNew York City, NY
HiringNo
Sitehttps://www.wyndly.com
Founded2020
YC group partnerJared Friedman
Previously known asWyndly Health

Pitching, partnering or investing alongside them? See who really runs and owns Wyndly.

Free to see. No signup.

Keep reading

More on Wyndly and the records around it.

Also in YC Winter 2021

Same batch, Healthcare first.

What do you want to do with Wyndly?

Get the full cited report on Wyndly

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Wyndly: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Wyndly (https://www.wyndly.com) fixes allergies by training patients' bodies to ignore their allergy triggers. Frustrated allergy suffers come to us when they no longer want to deal with pills and sprays. We diagnose the patient’s unique allergy profile and create a personalized treatment plan to give the patient lifelong allergy relief. Specifically, Wyndly is increasing access to sublingual immunotherapy (SLIT) for allergy care. For our patients, we're combining the convenience of telehealth and direct-to-consumer care with an exceptional patient experience that never loses the context of care. Wyndly represents an opportunity to change allergy care forever. With 60 million Americans suffering from allergies today, and with this number doubling over the coming years, there's simply an incredible need for the convenient care Wyndly provides. You can read more about us in Techcrunch. The Wyndly Model At Wyndly, we believe that better connections lead to better care, and we’re committed to making both happen at every step of the patient journey. Our allergy practice allows our patients to work with expert providers to develop personalized treatment plans for long-term allergy relief using clinically proven therapies. From a patient’s initial consultation to their final treatment delivery, we want the Wyndly experience to be a breath of fresh air for allergy sufferers – truly effective allergy relief, simply and efficiently delivered. Once we've conquered allergies, we're transforming the care model for every chronic condition. While transactional care for purchasing pills has flourished in telehealth, no one has gone after chronic care. Patients with chronic conditions are shuffled between providers, insurance, and more -- and they never feel heard. These patients deserve better, and we're going to give it to them. Wyndly is starting with allergies, but we'll expand into asthma, sleep apnea, and other conditions in the near future. Our values Compassion: We approach all our patients and partners with an open mind and a genuine desire to be of service. Focus: We do a few things very well, and are always clear about our boundaries and direction of travel. Courage: We embrace ambiguity and discomfort because we know that’s how we grow. Progress: We make something better every single day. *It boils down to empathy and forward momentum in everything we do.* The team Wyndly is proudly backed by Y Combinator and a leading group of angel investors and VCs. The founders are Dr. Manan Shah (Chief Medical Officer), an ear-nose-and-throat surgeon who’s a leading practitioner of telehealth in his specialty, and his cousin Aakash Shah (CEO), who led growth engineering at SparkGift (acquired by Stockpile in 2016) and Parse.ly (acquired by Automattic in 2021).

Want the whole picture on Wyndly?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Wyndly: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Wyndly covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Wyndly: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Wyndly. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups Consumer and social app startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Wyndly: Accepted into Y Combinator Winter 2021
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-wyndly
Last updated 2026-11-05
Primary record: Y Combinator directory entry
Wyndly (YC W21) — Life's better without allergies. MentionFox, 2026-11-05. https://mentionfox.com/funding/yc-wyndly